Koninklijke Philips vs Roivant Sciences

Koninklijke Philips (PHG), health care, and Roivant Sciences (ROIV), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Koninklijke Philips is worth $29.2B on the stock market and Roivant Sciences $28B: Koninklijke Philips is valued at 4% more. Koninklijke Philips's operating margin in its latest fiscal year was 7.98% and Roivant Sciences's -6236%. Over the past year Koninklijke Philips's share price has moved +9.64% and Roivant Sciences's +88.2%.

Key facts

Koninklijke Philips market value
$29.2B
Roivant Sciences market value
$28B
Koninklijke Philips P/E
26.0
Koninklijke Philips revenue
$19.8BFY to 2025-12-31
Roivant Sciences revenue
$8.3MFY to 2026-03-31
Superinvestors holding both
0

Market values as of .

Koninklijke Philips vs Roivant Sciences: every measure side by side
Measure Koninklijke Philips Roivant Sciences
SectorHealth CareHealth Care
Country Netherlands United Kingdom
Fiscal year ends2025-12-312026-03-31
Size
Market cap$29.2Bhigher$28Blower
Revenue$19.8Bhigher$8.3Mlower
Earnings$993Mhigher-$299.8Mlower
Employees63,909higher721lower
Total assets$29.9Bhigher$5.7Blower
Valuation
P/E26.0—
P/S1.5lower3396higher
P/B——
Dividend yield——
Profitability
Operating margin7.98%higher-6236%lower
Balance sheet
Net assets$12.2Bhigher$4.5Blower
Total liabilities$17.7Bhigher$416.3Mlower
Total debt$9B—
Cash on hand$3.1Bhigher$1.4Blower
Price change
Today-0.83%lower+0.26%higher
1 year+9.64%lower+88.2%higher

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (0)

None of the tracked investors.

Koninklijke Philips only (4)

Percentages are each holding's share of that investor's reported portfolio. Who owns PHG · Who owns ROIV

Further comparisons

Learn

Questions and answers

Which is bigger, Koninklijke Philips or Roivant Sciences?

By market value, Koninklijke Philips is the larger: $29.2B against $28B for Roivant Sciences. By revenue in its latest fiscal year, Koninklijke Philips is the larger: $19.8B against $8.3M for Roivant Sciences.

Which has the higher operating margin?

Koninklijke Philips: 7.98%, against -6236% for Roivant Sciences. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which superinvestors own both Koninklijke Philips and Roivant Sciences?

None of the tracked superinvestors holds both in their latest 13F filing. 4 hold Koninklijke Philips and 6 hold Roivant Sciences.

Cite this page

Funkfolio, “Koninklijke Philips vs Roivant Sciences”, data as of 18 November 2026. https://funkfolio.com/compare/phg-vs-roiv

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.